Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;44(1):11-13.
doi: 10.1080/0886022X.2021.2013887.

Duration of SARS-CoV-2 antigen positivity in hemodialysis patients

Jun Matsumoto  1 , Yosuke Saka  2 , Tetsushi Mimura  2 , Tomohiko Naruse  2
Affiliations
Comment

Duration of SARS-CoV-2 antigen positivity in hemodialysis patients

Jun Matsumoto et al. Ren Fail. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
Duration of SARS-CoV-2 antigen positivity in hemodialysis patients and non-hemodialysis patients hospitalized with COVID-19. The duration of SARS-CoV-2 antigen positivity was significantly longer in the HD group than the non-HD group (20 days vs 16 days; p = .022). After adjustment for hypertension, diabetes mellitus, and cough, which were the parameters which differed significantly between the groups, the duration of positive SARS-CoV-2 on antigen test remained longer in patients on hemodialysis (p = .036). HD: hemodialysis. *Statistically analysis after adjustment
See this image and copyright information in PMC

Comment on

References

    1. Yang X, Yu Y, Xu J, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. - PMC - PubMed
    1. Wang F, Ao G, Wang Y, et al. . Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis. Ren Fail. 2021;43(1):1394–1407. - PMC - PubMed
    1. De Meester J, De Bacquer D, Naesens M, et al. . Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study. J Am Soc Nephrol. 2021;32(2):385–396. - PMC - PubMed
    1. Attias P, Sakhi H, Rieu P, et al. . Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients. Kidney Int. 2021;99(6):1490–1492. - PMC - PubMed
    1. Forbes S, Davari M, Gnanasampanthan S, et al. . Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19. Nephrol Dial Transplant. 2021;36(7):1292–1297. - PMC - PubMed